SEC Form 4 · accession 0001127602-17-003431
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — Corporate Executive VP
Period of report
Jan 31, 2017
Accepted (ET)
Feb 2, 2017 · 8:21 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2017 | A | 27,750 | $0.00 | A | 49,299 | D | |
| Common Stock | Jan 31, 2017 | F | 11,226 | $78.38 | D | 38,073 | D | |
| Common Stock | holding | — | — | — | 30,493 | I | By Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 28, 2014.